Skip to content

Assessment of efficacy and safety of long-term use of rigid scleral lens for correction of corneal irregular astigmatism combined with myopia or hyperopia- a prospective, multi-center, single-treatment arm, clinical trial

Assessment of efficacy and safety of long-term use of rigid scleral lens for correction of corneal irregular astigmatism combined with myopia or hyperopia- a prospective, multi-center, single-treatment arm, clinical trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068547
Enrollment
Unknown
Registered
2023-02-23
Start date
2023-02-17
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

corneal irregular astigmatism combined with myopia or hyperopia

Interventions

Treatment group :Wear iFit scleral lenses

Sponsors

Eye Hospital of Wenzhou Medical University, The Eye, ear, nose and Throat Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 to 65 tears (inclusive), male or female 2. Having corneal irregular astigmatism combined with myopia or hyperopia 3. Willing to comply the examination and follow-up procedures

Exclusion criteria

Exclusion criteria: Cirtances judged by the investigator to be inappropriate to participate in the trial

Design outcomes

Primary

MeasureTime frame
Best corrected vision acuity;The number of adverse events;

Countries

China

Contacts

Public ContactJiang Jun

Eye Hospital of Wenzhou Medical University, The Eye, ear, nose and Throat Hospital Affiliated to Fudan University

jjhsj@hotmail.com13506511080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026